High-Risk Localized and Locally Advanced Prostate Cancer
Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for...
Bewaard in:
Andere auteurs: | |
---|---|
Formaat: | Elektronisch Hoofdstuk |
Taal: | Engels |
Gepubliceerd in: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Onderwerpen: | |
Online toegang: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
DOAB: download the publicationDOAB: description of the publication
3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |